Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Stomach Neoplasms 2Breast Neoplasms 2Smoldering Multiple Myeloma 1Psychological Well-Being 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Helicobacter Infections 1Fatigue Syndrome, Chronic 1Esophageal Neoplasms 1Diarrhea 1Breast Carcinoma In Situ 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 1dostarlimab 1Tyrosine Kinase Inhibitors 1Surveys and Questionnaires 1Semen Analysis 1Registries 1Radiosurgery 1Probiotics 1Patient Reported Outcome Measures 1Interviews as Topic 1Folfox protocol 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neoplasms, Second Primary × Probiotics × Clear all
NCT06998823 2025-05-31

The Effect of Survival, Response and Microbiota Change in Different Therapy Under Probiotic Supplement

Chang Gung Memorial Hospital

Phase NA Recruiting
120 enrolled
Tumor-Agnostic

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡